IP Library › Assignment 056152/0655
Patent Assignment
Reel/Frame 056152/0655

Assignment of Assignor's Interest

Recorded: 2021-05-06 Pages: 3
Assignor
CARSGEN THERAPEUTICS CO., LTD.
Executed: 2021-01-22
Assignee
CAFA THERAPEUTICS LIMITED
2/3 EXCHANGE PLACE, IFSC, DUBLIN, D01 AE27, IRELAND
Covered Properties (3)
Tumor-Specific Anti-Egfr Antibody and Application Thereof
Application: 15/746,711 →
Publication: US 2018/0327501
Antibody Against Glypican-3 and Application Thereof
Application: 15/750,271 →
Publication: US 2019/0046659
Fully Human Anti-Mesothelin Antibodies and Immune Effector Cells Targeting Mesothelin
Application: 15/754,076 →
Publication: US 2018/0244796
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 8, 2018
From: WANG, HUAMAO; SONG, BO
To: CARSGEN THERAPEUTICS LTD
Reel/Frame 046585/0438 →
Assignment of Assignor's Interest Aug 8, 2018
From: WANG, HUAMAO; SONG, BO; WANG, PENG
To: CARSGEN THERAPEUTICS, LTD
Reel/Frame 046587/0698 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 046587 Frame: 0698. Assignor(S) Hereby Confirms the Assignment . Aug 25, 2020
From: WANG, HUAMAO; SONG, BO; WANG, PENG
To: CARSGEN THERAPEUTICS CO., LTD.
Reel/Frame 053596/0246 →
Assignment of Assignor's Interest Jan 15, 2021
From: WANG, HUAMAO; SONG, BO
To: SHANGHAI YIJIE BIOTECHNOLOGY CO. LTD
Reel/Frame 054929/0449 →
Assignment of Assignor's Interest Jan 15, 2021
From: SHANGHAI YIJIE BIOTECHNOLOGY CO. LTD
To: CARSGEN THERAPEUTICS CO., LTD.
Reel/Frame 054932/0192 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 046585 Frame 0438. Assignor(S) Hereby Confirms the Assignment. Feb 9, 2021
From: WANG, HUAMAO; SONG, BO
To: CARSGEN THERAPEUTICS CO., LTD.
Reel/Frame 055874/0114 →
Assignment of Assignor's Interest Jun 15, 2022
From: CAFA THERAPEUTICS LIMITED
To: CRAGE MEDICAL CO., LIMITED
Reel/Frame 060208/0935 →